Susan Hasty, Publisher
Table of Contents . . . March 31st, 2003Non-Subscriber - Summaries Only
Hypogonadism - Testosterone product to be commercialized
Ischemic Stroke - Argatroban meets primary endpoints in phase II study
Corporate Update - Product, pipeline update provided by cancer drug maker
Microfluidics - Two new LabChip devices introduced for drug discovery screening
Antiviral Therapy - Interim data to be presented on phase IIb study in HIV/AIDS
Cardiology Diagnostics - FDA clearance granted for new chest pain screen
Chemotherapy - Antinausea drug will likely get approval in U.S.
Chronic Myeloid Leukemia - Medical journal editorial dubs Gleevec "gold standard"
Corporate Learning - Case study challenge expands to foster skills development
Drug Development - Agreement provides ability to use Captisol for early development
Drug Development - FDA issues follow-up statement on unapproved long-acting Guaifenesin
Finance - Biotech company loses $997,000 in 2002
Hyperglycemia - Generic formulation of diabetes drug produced
Personal Care Trends - UV absorber suppliers look to Asia for long-term market growth
Protein Analysis - Fully automated chip-based nanoelectrospray launched
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.